I need to step back:
Thanks, GD, Lightrock, Robot and others...I'm lost on the nitty gritty of the Multikine Trial breakdown (so I think, again, that I am not at all qualified to even speak to it).
However, I would think that considering the insider warrants and expirations (and "extensions" without notice) are things to consider.
Additionally, I agree with GD that submitting the abstracts for ASCO's deadline would be a statement of confidence after all the pep talks expressed by Geert in recent days prior to the SHARP selloff from, let's say 25-27 and ignoring $30 to $40 which was lost in a New York Minute!!!
So, as I see it, we are down about $5 from a reasonable price range. Option expiration is another thing
Sushi should get props for suggesting a lower price level; I think he sees $18 or so as realistic.
I am glad I lightened up by 50% of my position with a better comfort level now. Good luck, we broke the prior low and are now dealing with the spike low one day after $40'ish was hit...
wow....that was quick and dirty.